Arce J-C, Balen A, Platteau P, Pettersson G, Andersen A Nyboe
Ferring Pharmaceuticals A/S, Reproductive Health, Global Clinical and Non-Clinical R & D, Copenhagen, Denmark.
Leeds General Infirmary, Department of Obstetrics and Gynaecology, Leeds, UK.
Reprod Biomed Online. 2011 May;22(5):449-56. doi: 10.1016/j.rbmo.2011.01.006. Epub 2011 Jan 22.
This retrospective study investigated whether mid-luteal serum progesterone concentrations are associated with live birth rates in women with WHO group II anovulatory infertility undergoing ovulation induction. Data were from women (n=335) stimulated with gonadotrophins using a low-dose step-up protocol, of which women with presumptive ovulation (n=279), defined as a mid-luteal progesterone concentration ⩾7.9ng/ml (⩾25nmol/l; range 7.9-194ng/ml) were included. Of the women with presumptive ovulation, 57 (20.4%) had a live birth and their serum mid-luteal progesterone concentration was significantly (P=0.016) higher than that of the non-live birth group. There were significant associations between the number of large (⩾15mm) and medium-sized follicles (12-14mm) at human chorionic gonadotrophin administration and the mid-luteal progesterone concentration (P<0.001), while the total number of large and medium-sized follicles was not significantly associated with live birth rate. In conclusion, mid-luteal progesterone concentrations above the cut-off values currently used for defining ovulation were positively associated with live birth rates in normogonadotrophic anovulatory women undergoing ovulation induction with gonadotrophins. The mid-luteal progesterone concentration, apart from being a consequence of the number of corpora lutea, may also reflect the quality of the follicle/oocyte/corpus luteum. Measurement of blood concentration of the steroid hormone progesterone in the mid-postovulatory phase of the menstrual cycle is frequently used to determine ovulation. The aim of this study was to investigate whether increasing blood concentrations of progesterone in the mid-postovulatory phase was associated with higher chances of achieving a live birth in a group of 335 women with anovulatory infertility, who had undergone stimulation with gonadotrophin hormones for the purpose of inducing ovulation. Statistical analysis, performed on the 279 women with presumptive ovulation (defined as a mid-postovulatory progesterone concentration ⩾7.9ng/ml serum), showed that the mid-postovulatory progesterone concentration was significantly positively associated with live birth rate. There was also a significant association between follicular development at end of gonadotrophin stimulation and the mid-postovulatory progesterone concentration, but follicular development could not explain live birth rate as mid-postovulatory progesterone concentrations could. In conclusion, increased blood concentrations of progesterone in the mid-postovulatory phase of the menstrual cycle above the threshold values currently used for defining ovulation were associated with increased live birth rates in anovulatory women undergoing ovulation induction with gonadotrophin hormones. The mid-postovulatory progesterone concentration, apart from being a consequence of the quantity of follicular development, may therefore also reflect the quality of the ovarian follicles and eggs.
这项回顾性研究调查了在接受促排卵治疗的世界卫生组织II型无排卵性不孕女性中,黄体中期血清孕酮浓度是否与活产率相关。数据来自335名使用低剂量递增方案接受促性腺激素刺激的女性,其中黄体中期孕酮浓度≥7.9ng/ml(≥25nmol/l;范围7.9 - 194ng/ml)的推测有排卵的女性(n = 279)被纳入研究。在推测有排卵的女性中,57名(20.4%)活产,她们的血清黄体中期孕酮浓度显著高于未活产组(P = 0.016)。在注射人绒毛膜促性腺激素时,大卵泡(≥15mm)和中等大小卵泡(12 - 14mm)的数量与黄体中期孕酮浓度之间存在显著关联(P<0.001),而大卵泡和中等大小卵泡的总数与活产率无显著关联。总之,在接受促性腺激素促排卵的正常促性腺激素性无排卵女性中,高于目前用于定义排卵的临界值的黄体中期孕酮浓度与活产率呈正相关。黄体中期孕酮浓度除了是黄体数量的结果外,还可能反映卵泡/卵母细胞/黄体的质量。在月经周期的排卵后中期测量类固醇激素孕酮的血浓度常用于确定排卵。本研究的目的是调查在一组335名无排卵性不孕且接受促性腺激素刺激以诱导排卵的女性中,排卵后中期孕酮血浓度升高是否与更高的活产几率相关。对279名推测有排卵的女性(定义为排卵后中期孕酮血清浓度≥7.9ng/ml)进行的统计分析表明,排卵后中期孕酮浓度与活产率显著正相关。在促性腺激素刺激结束时的卵泡发育与排卵后中期孕酮浓度之间也存在显著关联,但卵泡发育无法像排卵后中期孕酮浓度那样解释活产率。总之,月经周期排卵后中期高于目前用于定义排卵的阈值的孕酮血浓度升高与接受促性腺激素诱导排卵的无排卵女性活产率增加相关。因此,排卵后中期孕酮浓度除了是卵泡发育数量的结果外,还可能反映卵巢卵泡和卵子的质量。